Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96BH3: Variant p.Glu199Lys

Epididymal sperm-binding protein 1
Gene: ELSPBP1
Feedback?
Variant information Variant position: help 199 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glutamate (E) to Lysine (K) at position 199 (E199K, p.Glu199Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 199 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 223 The length of the canonical sequence.
Location on the sequence: help GFPCHFPFNYKNKNYFNCTN E GSKENLVWCATSYNYDQDHT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GFPCHFPFNYKNKNYFNCTNEGSKENLVWCATSYNYDQDHT

                              GFPCHFPFSYKNKNYYNCIGKGTKENLTWCATSYNYDRDHT

Pig                           GFPCHFPFNYKNKNYFNCTTKGSKENLLWCATSYNYDQDHT

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 25 – 223 Epididymal sperm-binding protein 1
Domain 177 – 223 Fibronectin type-II 4
Glycosylation 195 – 195 N-linked (GlcNAc...) asparagine
Disulfide bond 182 – 208
Disulfide bond 196 – 223



Literature citations
Novel sperm-binding proteins of epididymal origin contain four fibronectin type II-modules.
Saalmann A.; Muenz S.; Ellerbrock K.; Ivell R.; Kirchhoff C.;
Mol. Reprod. Dev. 58:88-100(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANT LYS-199; A new human homolog 1 of bovine seminal plasma proteins.
Luo Y.; Zhang X.; Yu B.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT LYS-199; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT LYS-199;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.